H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival.

Saravi, Sayeh; Katsuta, Eriko; Jeyaneethi, Jeyarooban; Amin, Hasnat A; Kaspar, Matthias; Takabe, Kazuaki; Pados, George; Drenos, Fotios; Hall, Marcia; Karteris, Emmanouil

Saravi, Sayeh; Katsuta, Eriko; Jeyaneethi, Jeyarooban; Amin, Hasnat A; Kaspar, Matthias; Takabe, Kazuaki; Pados, George; Drenos, Fotios; Hall, Marcia; Karteris, Emmanouil.

Affiliation

Saravi S; Department of Life Sciences, Brunel University London, Uxbridge UB83PH, UK.
Katsuta E; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Jeyaneethi J; Department of Life Sciences, Brunel University London, Uxbridge UB83PH, UK.
Amin HA; Department of Life Sciences, Brunel University London, Uxbridge UB83PH, UK.
Kaspar M; Department of Life Sciences, Brunel University London, Uxbridge UB83PH, UK.
Takabe K; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Pados G; 1st Department of OB-GYN, Aristotle University, 541 24 Thessaloniki, Greece.
Drenos F; Department of Life Sciences, Brunel University London, Uxbridge UB83PH, UK.
Hall M; Department of Life Sciences, Brunel University London, Uxbridge UB83PH, UK.
Karteris E; Mount Vernon Cancer Centre, Middlesex, Northwood HA6 2RN, UK.

J Clin Med ; 9(9)2020 Sep 02.

Article de En | MEDLINE | ID: mdl-32887437

Mots clés

H2AX; biomarker; ovarian cancer; polymorphisms

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: J Clin Med Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google